SAN DIEGO-Tuesday, April 3rd 2018 [ AETOS Wire ] (BUSINESS WIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today. As CTO, Ghoshal will lead ResMed’s global healthcare informatics and data analytics team to drive its world-leading cloud-based digital health platforms as well as investments in emerging health technologies like artificial intelligence and machine learning. Ghoshal has more than 25 years’ experience in information technology, semiconductor innovation, digital strategy, information security, advanced analytics, operations and customer care. Since 2016, Ghoshal has been chief operating officer at Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care. From 2012 to 2016, he was vice president of information technology at ResMed. Previously, Ghoshal worked in a number of management and technical roles in the semiconductor and financial industries. ... Read more »

Gemalto SafeNet KeySecure integration with NetApp provides centralized key management for thousands of volumes across multiple clusters AMSTERDAM -Tuesday, April 3rd 2018 [ AETOS Wire ] (BUSINESS WIRE)-- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today announced that SafeNet KeySecure has been validated for use with the latest release of NetApp® Volume Encryption (NVE) data management solution. As a result, NetApp customers do not need to encrypt the entire disk drive; they can choose to encrypt granularly at the volume level without the need and additional cost of purchasing self encrypting drives (SEDs), while retaining key benefits such as centralized key management and access control, better compliance, and high availability. Data privacy and data security continues to be a key focus for organizations, especially in light of industry compliance standards such as US health standard (HIPAA) or payment card standard (PCI-DSS) and the EU’s General Da ... Read more »

COLOMBES, France-Saturday, March 31st 2018 [ AETOS Wire ] (BUSINESS WIRE) -- IDEMIA, the global leader in Augmented Identity, today announces its presence at Seamless Middle East 2018, the Middle East’s largest exhibition covering the world of Payments and Fintech in Dubai, on 15th and 16th April 2018. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, IDEMIA guarantees secure, authenticated and verifiable transactions for clients from Financial, Telecom, Identity, Public Security and IoT sectors. At Seamless Middle East 2018, IDEMIA invites you to experience its solutions to reinvent the way we “Transact” and “Identify”, through dedicated demonstration areas. A wide range of innovations will be showcased on the IDEMIA booth: Know Your Customer solutions for digital customer onboarding 3D face and iris recognition for mobile phones Digital customer experience and adaptive authentication for Financial Institutions ... Read more »

IRVING, Texas & CAIRO-Wednesday, March 28th 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Fluor Corporation (NYSE: FLR) announced today that it was awarded the front-end engineering design (FEED) contract by Egypt’s state energy firm Enppi for the offsites and utilities portion of the main plant complex and support services for the Waphco phosphoric acid production plant at Abu Tartour, in the Egyptian province of New Valley. Fluor will book the undisclosed contract value in the first quarter of 2018. The contract signing ceremony was held earlier this month in Cairo and was presided over by His Excellency Mr. Tarek El Molla, minister of Petroleum and Natural Resources of the Arab Republic of Egypt. “Fluor appreciates the importance and relevance to Egypt of this major industrial project and will use its experienced resources and subject matter expertise to deliver this complex engineering project to meet our client’s goals,” said Tony Morgan, president of Fluor’s Mining & Metals business. ... Read more »

DAEJEON, South Korea-Monday, April 2nd 2018 [ AETOS Wire ] (BUSINESS WIRE) -- PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma Multiforme.” “We are very pleased with this Orphan Drug Designation from FDA for TTAC-0001 for GBM treatment since we have been preparing for clinical studies of TTAC-0001 plus KEYTRUDA® (pembrolizumab) combo therapy for recurrent GBM in addition to TTAC-0001 mono therapy for recurrent GBM progressed after bevacizumab treatment. It will accelerate the progress of TTAC-0001 to provide clinical benefit in the treatment of GBM,” said Dr. Jin-San Yoo, president and chief executive officer of PharmAbcine, Inc. The FDA Office of Orphan Products Development grants Orphan Drug Designation to investigational drugs and biologic ... Read more »

TOKYO-Monday, April 2nd 2018 [ AETOS Wire ] (BUSINESS WIRE) -- Nobuaki Kurumatani today took office as the first Chairman and CEO of Toshiba Corporation (TOKYO:6502) to be appointed from outside the company in over 50 years. Commenting on his appointment as Representative Executive Officer and Chairman and CEO, Mr. Kurumatani said, “I am honored to be appointed CEO, and very much aware of the responsibilities I take on. Toshiba is not just any company. Its corporate DNA has realized countless Japan- and world-first technologies and products, made Toshiba a source of pride in Japan for nearly 145 years, and also made us a global leader. “I believe that helping Toshiba back on its feet is my true calling. I am here at Toshiba to support change and transformation, and I see my role as to build on the company’s resilience and to lead its recovery. To secure growth, we must radically improve our earning power and reinforce our finances. We must move out of our comfort zone and promote fu ... Read more »